Literature DB >> 2210971

Reactive oxygen species and hyaluronate in serum and synovial fluid in arthritis.

H Saari1, T Sorsa, Y T Konttinen.   

Abstract

Oxygen-derived free radicals (ODFR) depolymerized synovial-fluid (SF) hyaluronic acid (HA) when hypoxanthine/xanthine oxidase (HX/XAO) was used as the radical generator. The molecular-weight distribution of ODFR-induced SF HA degradation products was determined using high performance liquid chromatography (HPLC) with TSK 5000 PW or TSK 6000 PW size-exclusion columns and simultaneously using 125I-labelled hyaluronate-binding protein (125I-HABP) assay. The exposure of SF HA to hydroxyl-radical flux resulted in the formation of a degradation product having a molecular weight of 13.5 X 10(3) daltons, from which no further degradation was achieved. If the iron chelator desferrioxamine and hydroxyl-radical scavenger mannitol were present in the reaction mixture, the HA peak decreased by 30-50%, as a result of reaction with superoxide radical and hydrogen peroxide. These results show that superoxide radical and hydroxyl radical may have different modes of action on SF HA. The molecular-weight distribution of serum HA from patients with rheumatoid arthritis varied in different individuals and ranged between 275 X 10(3) and 650 X 10(3).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210971

Source DB:  PubMed          Journal:  Int J Tissue React        ISSN: 0250-0868


  8 in total

1.  Effects of intravenous iron saccharate on improving severe anemia in rheumatoid arthritis patients.

Authors:  Wei-Sheng Chen; Chun-Yu Liu; Hui-Ting Lee; Kelvin Tsai; Yi-Chun Lin; Der-Cherng Tarng; Chao-Hung Ho; Hsiao-Yi Lin
Journal:  Clin Rheumatol       Date:  2011-10-29       Impact factor: 2.980

2.  Differential effects of reactive oxygen species on native synovial fluid and purified human umbilical cord hyaluronate.

Authors:  H Saari; Y T Konttinen; C Friman; T Sorsa
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

3.  Biophysical properties of phenyl succinic acid derivatised hyaluronic acid.

Authors:  Maria Teresa Neves-Petersen; Søren Klitgaard; Esben Skovsen; Steffen B Petersen; Kristoffer Tømmeraas; Khadija Schwach-Abdellaoui
Journal:  J Fluoresc       Date:  2009-11-28       Impact factor: 2.217

4.  Effect of interleukin-1 on hyaluronate synthesis by synovial fibroblastic cells.

Authors:  Y T Konttinen; H Saari; D C Nordström
Journal:  Clin Rheumatol       Date:  1991-06       Impact factor: 2.980

Review 5.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

Review 6.  Serotherapy against Voltage-Gated Sodium Channel-Targeting αToxins from Androctonus Scorpion Venom.

Authors:  Marie-France Martin-Eauclaire; Sonia Adi-Bessalem; Djelila Hammoudi-Triki; Fatima Laraba-Djebari; Pierre E Bougis
Journal:  Toxins (Basel)       Date:  2019-01-23       Impact factor: 4.546

7.  Usefulness of serum hyaluronic acid levels as a predictor of incidence of hand osteoarthritis analyzed by longitudinal analysis from the Iwaki cohort.

Authors:  Tatsuro Saruga; Eiji Sasaki; Ryo Inoue; Daisuke Chiba; Seiya Ota; Hiroki Iwasaki; Ryoko Uesato; Shigeyuki Nakaji; Yasuyuki Ishibashi
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

Review 8.  Review of the Mechanism of Action for Supartz FX in Knee Osteoarthritis.

Authors:  Roy D Altman; Vinod Dasa; Jun Takeuchi
Journal:  Cartilage       Date:  2016-12-29       Impact factor: 4.634

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.